TY - JOUR
T1 - Correction
T2 - Dysfunction of different cellular degradation pathways contributes to specific β-amyloid42-induced pathologies (FASEB Journal (2018) 32 (1375-1387) DOI: 10.1096/fj.201700199RR)
AU - Ji, Xuan Ru
AU - Cheng, Kuan Chung
AU - Chen, Yu Ru
AU - Lin, Tzu Yu
AU - Cheung, Chun Hei Antonio
AU - Wu, Chia Lin
AU - Chiang, Hsueh Cheng
N1 - Publisher Copyright:
© FASEB.
PY - 2018/11
Y1 - 2018/11
N2 - In the article, "Dysfunction of different cellular degradation pathways contributes to specific b-amyloid42-induced pathologies" by Xuan-Ru Ji, Kuan-Chung Cheng, Yu-Ru Chen, Tzu-Yu Lin, Chun Hei Antonio Cheung, Chia-LinWu, andHsueh-Cheng Chiang, in FASEB J.March 2018 32: 1375-1387 (doi: 10.1096/fj.201700199RR), there is an error in the author affiliations. The correct author list and affiliations are as follows: Xuan-Ru Ji,∗,1 Kuan-Chung Cheng,∗,†,1 Yu-Ru Chen,∗ Tzu-Yu Lin,∗ Chun Hei Antonio Cheung,∗,†Chia-Lin Wu,‡,,{ and Hsueh-Cheng Chiang∗,†,2 ∗Department of Pharmacology and †Institute of Basic Medical Sciences, College of Medicine, National Cheng-Kung University, Tainan, Taiwan; ‡Department of Biochemistry and Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan; and {Department of Neurology, Chang Gung Memorial Hospital, Linkou, Taiwan 1These authors contributed equally to this work. 2Correspondence:NationalCheng-KungUniversity,No.1,UniversityRd., Nainan City 701, Taiwan. E-mail: [email protected] This error has been corrected online.
AB - In the article, "Dysfunction of different cellular degradation pathways contributes to specific b-amyloid42-induced pathologies" by Xuan-Ru Ji, Kuan-Chung Cheng, Yu-Ru Chen, Tzu-Yu Lin, Chun Hei Antonio Cheung, Chia-LinWu, andHsueh-Cheng Chiang, in FASEB J.March 2018 32: 1375-1387 (doi: 10.1096/fj.201700199RR), there is an error in the author affiliations. The correct author list and affiliations are as follows: Xuan-Ru Ji,∗,1 Kuan-Chung Cheng,∗,†,1 Yu-Ru Chen,∗ Tzu-Yu Lin,∗ Chun Hei Antonio Cheung,∗,†Chia-Lin Wu,‡,,{ and Hsueh-Cheng Chiang∗,†,2 ∗Department of Pharmacology and †Institute of Basic Medical Sciences, College of Medicine, National Cheng-Kung University, Tainan, Taiwan; ‡Department of Biochemistry and Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan; and {Department of Neurology, Chang Gung Memorial Hospital, Linkou, Taiwan 1These authors contributed equally to this work. 2Correspondence:NationalCheng-KungUniversity,No.1,UniversityRd., Nainan City 701, Taiwan. E-mail: [email protected] This error has been corrected online.
UR - http://www.scopus.com/inward/record.url?scp=85055864824&partnerID=8YFLogxK
U2 - 10.1096/fj.201700199RRERR
DO - 10.1096/fj.201700199RRERR
M3 - 评论/辩论
AN - SCOPUS:85055864824
SN - 0892-6638
VL - 32
SP - 6354
JO - FASEB Journal
JF - FASEB Journal
IS - 11
ER -